메뉴 건너뛰기




Volumn 57, Issue 1, 2013, Pages 80-83

Analytical sensitivity of three real-time PCR assays for measuring subtype B HIV-1 RNA

Author keywords

HIV RNA quantification; Limit of detection; Reproducibility

Indexed keywords

VIRUS RNA;

EID: 84875808754     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.12.017     Document Type: Article
Times cited : (9)

References (14)
  • 1
    • 84863115427 scopus 로고    scopus 로고
    • Plasma HIV-1 RNA detection below 50copies/mL and risk of virologic rebound in patients receiving highly active antiretroviral therapy
    • Doyle T., Smith C., Vitiello P., Cambiano V., Johnson M., Owen A., et al. Plasma HIV-1 RNA detection below 50copies/mL and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis 2012, 54(5):724-732.
    • (2012) Clin Infect Dis , vol.54 , Issue.5 , pp. 724-732
    • Doyle, T.1    Smith, C.2    Vitiello, P.3    Cambiano, V.4    Johnson, M.5    Owen, A.6
  • 2
    • 56749149574 scopus 로고    scopus 로고
    • Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy
    • Geretti A.M., Smith C., Haberl A., Garcia-Diaz A., Nebbia G., Johnson M., et al. Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy. Antivir Ther 2008, 13(7):927-936.
    • (2008) Antivir Ther , vol.13 , Issue.7 , pp. 927-936
    • Geretti, A.M.1    Smith, C.2    Haberl, A.3    Garcia-Diaz, A.4    Nebbia, G.5    Johnson, M.6
  • 3
    • 34547478269 scopus 로고    scopus 로고
    • Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study
    • Mocroft A., Phillips A.N., Gatell J., Ledergerber B., Fisher M., Clumeck N., et al. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 2007, 370(9585):407-413.
    • (2007) Lancet , vol.370 , Issue.9585 , pp. 407-413
    • Mocroft, A.1    Phillips, A.N.2    Gatell, J.3    Ledergerber, B.4    Fisher, M.5    Clumeck, N.6
  • 5
    • 78149491596 scopus 로고    scopus 로고
    • Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification
    • Yan C.S., Hanafi I., Kelleher A.D., Carr A.D., Amin J., McNally L.P., et al. Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification. J Clin Virol 2010, 49(4):249-253.
    • (2010) J Clin Virol , vol.49 , Issue.4 , pp. 249-253
    • Yan, C.S.1    Hanafi, I.2    Kelleher, A.D.3    Carr, A.D.4    Amin, J.5    McNally, L.P.6
  • 6
    • 0004116672 scopus 로고
    • Cambridge University Press, Cambridge
    • Finney D.J. Probit analysis 1971, Cambridge University Press, Cambridge. 3rd ed.
    • (1971) Probit analysis
    • Finney, D.J.1
  • 7
    • 77950490354 scopus 로고    scopus 로고
    • Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification
    • Damond F., Avettand-Fenoel V., Collin G., Roquebert B., Plantier J.C., Ganon A., et al. Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification. J Clin Microbiol 2010, 48(4):1413-1416.
    • (2010) J Clin Microbiol , vol.48 , Issue.4 , pp. 1413-1416
    • Damond, F.1    Avettand-Fenoel, V.2    Collin, G.3    Roquebert, B.4    Plantier, J.C.5    Ganon, A.6
  • 8
    • 77955652621 scopus 로고    scopus 로고
    • Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach
    • Sizmann D., Glaubitz J., Simon C.O., Goedel S., Buergisser P., Drogan D., et al. Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach. J Clin Virol 2010, 49(1):41-46.
    • (2010) J Clin Virol , vol.49 , Issue.1 , pp. 41-46
    • Sizmann, D.1    Glaubitz, J.2    Simon, C.O.3    Goedel, S.4    Buergisser, P.5    Drogan, D.6
  • 9
    • 67249121143 scopus 로고    scopus 로고
    • Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
    • Dinoso J.B., Kim S.Y., Wiegand A.M., Palmer S.E., Gange S.J., Cranmer L., et al. Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci USA 2009, 106(23):9403-9408.
    • (2009) Proc Natl Acad Sci USA , vol.106 , Issue.23 , pp. 9403-9408
    • Dinoso, J.B.1    Kim, S.Y.2    Wiegand, A.M.3    Palmer, S.E.4    Gange, S.J.5    Cranmer, L.6
  • 10
    • 77749277080 scopus 로고    scopus 로고
    • Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy
    • McMahon D., Jones J., Wiegand A., Gange S.J., Kearney M., Palmer S., et al. Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis 2010, 50(6):912-919.
    • (2010) Clin Infect Dis , vol.50 , Issue.6 , pp. 912-919
    • McMahon, D.1    Jones, J.2    Wiegand, A.3    Gange, S.J.4    Kearney, M.5    Palmer, S.6
  • 12
    • 70449411747 scopus 로고    scopus 로고
    • HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy
    • Mavigner M., Delobel P., Cazabat M., Dubois M., L'Faqihi-Olive F.-E., Raymond S., et al. HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy. PLoS ONE 2009, 4(10):e7658.
    • (2009) PLoS ONE , vol.4 , Issue.10
    • Mavigner, M.1    Delobel, P.2    Cazabat, M.3    Dubois, M.4    L'Faqihi-Olive, F.-E.5    Raymond, S.6
  • 13
    • 84155162676 scopus 로고    scopus 로고
    • Low-level viraemia on HAART: significance and management
    • Doyle T., Geretti A.M. Low-level viraemia on HAART: significance and management. Curr Opin Infect Dis 2012, 25(1):17-25.
    • (2012) Curr Opin Infect Dis , vol.25 , Issue.1 , pp. 17-25
    • Doyle, T.1    Geretti, A.M.2
  • 14
    • 84873367194 scopus 로고    scopus 로고
    • Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia
    • Naeth G., Ehret R., Wiesmann F., Braun P., Knechten H., Berger A., et al. Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia. Med Microbiol Immunol 2012 Jun 15.
    • (2012) Med Microbiol Immunol
    • Naeth, G.1    Ehret, R.2    Wiesmann, F.3    Braun, P.4    Knechten, H.5    Berger, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.